The long-term effectiveness of steroid injections in primary acromioclavicular joint arthritis: a five-year prospective study.
We evaluated the long-term benefits of steroid injection in 25 shoulders in 20 consecutive patients (average age, 55 years) with primary acromioclavicular arthritis. Minimum follow-up was 5 years. The mean preinjection Constant score (61 points) improved at 6 months to 81 points, (mean difference, 19.36; P < .01). Improvement at 12 months (mean, 86 points) was also significant vs the 6-month score (P = .001). The mean score at 5 years (81 points) was a significant deterioration vs the 12-month score (P = .01) but still a significant improvement vs the preinjection scores (P < .0005). Younger patients had greater improvement in the objective score (range of movement and power; r = -0.47; P = .01), as did women (r = 0.405; P = .05). Local steroid injection is an effective treatment for primary isolated acromioclavicular arthritis. Improvement continues for at least 12 months. The benefit is felt up to 5 years. Pain relief tends to diminish long-term.
Hossain
Saqif
S
Department of Orthopaedic and Trauma, The Royal Oldham Hospital, Oldham, United Kingdom. hossains2000@yahoo.co.uk
Jacobs
Leo G H
LG
Hashmi
Rashid
R
D000173:Acromioclavicular Joint; D000328:Adult; D000368:Aged; D001168:Arthritis / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007270:Injections, Intra-Articular; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077555:Methylprednisolone Acetate; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome
D005938:Glucocorticoids; D000077555:Methylprednisolone Acetate; D008775:Methylprednisolone